These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 16205918)

  • 1. Nicotine as a typical drug of abuse in experimental animals and humans.
    Le Foll B; Goldberg SR
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):367-81. PubMed ID: 16205918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nicotine in experimental animals and humans: an update on addictive properties.
    Le Foll B; Goldberg SR
    Handb Exp Pharmacol; 2009; (192):335-67. PubMed ID: 19184655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute nicotine reinforcement, but not chronic tolerance, predicts withdrawal and relapse after quitting smoking.
    Perkins KA; Broge M; Gerlach D; Sanders M; Grobe JE; Cherry C; Wilson AS
    Health Psychol; 2002 Jul; 21(4):332-9. PubMed ID: 12090675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of nicotine in smoking: a dual-reinforcement model.
    Caggiula AR; Donny EC; Palmatier MI; Liu X; Chaudhri N; Sved AF
    Nebr Symp Motiv; 2009; 55():91-109. PubMed ID: 19013940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans.
    Le Foll B; Goldberg SR
    Trends Pharmacol Sci; 2005 Jun; 26(6):287-93. PubMed ID: 15925703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alternative reinforcer and craving on the choice to smoke cigarettes in the laboratory.
    Bisaga A; Padilla M; Garawi F; Sullivan MA; Haney M
    Hum Psychopharmacol; 2007 Jan; 22(1):41-7. PubMed ID: 17149785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rodent models for nicotine withdrawal.
    Chellian R; Behnood-Rod A; Bruijnzeel DM; Wilson R; Pandy V; Bruijnzeel AW
    J Psychopharmacol; 2021 Oct; 35(10):1169-1187. PubMed ID: 33888006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects.
    Higgins ST; Heil SH; Sigmon SC; Tidey JW; Gaalema DE; Stitzer ML; Durand H; Bunn JY; Priest JS; Arger CA; Miller ME; Bergeria CL; Davis DR; Streck JM; Zvorsky I; Redner R; Vandrey R; Pacek LR
    Psychopharmacology (Berl); 2017 Jan; 234(1):89-98. PubMed ID: 27714427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental determinants of the reinforcing effects of nicotine in humans.
    Hughes JR
    J Subst Abuse; 1989; 1(3):319-29. PubMed ID: 7580222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement.
    Chaudhri N; Caggiula AR; Donny EC; Palmatier MI; Liu X; Sved AF
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):353-66. PubMed ID: 16240165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of nicotine withdrawal: intracranial self-stimulation and somatic signs of withdrawal.
    Bauzo RM; Bruijnzeel AW
    Methods Mol Biol; 2012; 829():257-68. PubMed ID: 22231819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disrupting nicotine reinforcement: from cigarette to brain.
    Rose JE
    Ann N Y Acad Sci; 2008 Oct; 1141():233-56. PubMed ID: 18991961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking and addiction.
    Cohen C; Pickworth WB; Henningfield JE
    Clin Chest Med; 1991 Dec; 12(4):701-10. PubMed ID: 1747988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats.
    O'Dell LE; Torres OV; Natividad LA; Tejeda HA
    Neurotoxicol Teratol; 2007; 29(1):17-22. PubMed ID: 17184972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of beliefs regarding drug assignment in experimental and field studies of nicotine delivery devices: a review.
    Dar R; Barrett SP
    J Psychopharmacol; 2014 Nov; 28(11):1071-9. PubMed ID: 25253274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716).
    Cohen C; Perrault G; Griebel G; Soubrié P
    Neuropsychopharmacology; 2005 Jan; 30(1):145-55. PubMed ID: 15292905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide systems and new treatments for nicotine addiction.
    Bruijnzeel AW
    Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Motives for smoking and their correlates in clients attending Stop Smoking treatment services.
    McEwen A; West R; McRobbie H
    Nicotine Tob Res; 2008 May; 10(5):843-50. PubMed ID: 18569758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, crossover study on an electronic vapour product, a nicotine inhalator and a conventional cigarette. Part B: Safety and subjective effects.
    Walele T; Sharma G; Savioz R; Martin C; Williams J
    Regul Toxicol Pharmacol; 2016 Feb; 74():193-9. PubMed ID: 26702788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.